Iran's cancer patients are facing an impossible choice: a single chemotherapy session now costs six times the monthly minimum wage. Doctors report that more patients are delaying or abandoning treatment altogether, as drug prices soar and supplies run short.
A session at six times the minimum wage
The cost of one chemotherapy session in Iran now equals six times what a worker earns in a month. That's a barrier that puts treatment out of reach for many families, even before the broader economic strain. The number is a stark measure of how badly inflation has hit the country's healthcare system.
📊 Market Data Snapshot
Drug prices climb, supply runs thin
Drug prices are climbing across the board, and shortages are becoming common. It's not just the cost that hurts—it's the unpredictability of finding the medicine at all. For a cancer patient, that kind of uncertainty can be as dangerous as the disease itself.
Doctors see patients dropping off
Doctors report that more patients are already delaying or abandoning their treatment plans. Some can't afford the cost; others simply can't get the drugs. The combination is pushing people into decisions they never thought they'd have to make.
The crypto backdrop
This isn't the kind of news that moves Bitcoin's price this hour. But it's part of a pattern that matters for crypto: when a sanctioned economy hits this point, people start looking for ways to preserve their savings outside the system. Iran's crisis is a reminder of why Bitcoin's store-of-value narrative still resonates, even if the direct connection is hard to measure. For now, the focus is on patients, and the long-term questions about how these crises fuel adoption will remain.
It's unclear how long the shortages will last or how many patients will be forced to make the choice. That's the reality on the ground in Iran right now.
